bioRxivSystems BiologyPreprint
Textural features for pathway-level representation of omics data in biological networks
Abstract
More than 50 years ago, Haralick and co-authors proposed a family of gray-level co-occurrence statistics that became known as textural features. These features are widely used in image analysis, but their application to biological networks has remained limited because cellular networks are sparse, irregular graphs rather than regular pixel grids. This work presents a network-adapted version of Haralick texture analysis for generating pathway-level features from gene-level omics profiles. The resulting profiles reduce dimensionality and can be used as candidate predictors of anti-cancer drug response. Performance of these features is compared with original gene expression variables and with pathway features from network enrichment analysis (NEA), whose robustness has been demonstrated previously. Although technically simpler than NEA, Haralick features showed comparable sensitivity. More importantly, selected Haralick features were preserved between in vitro drug screens and clinical treatment-associated survival analyses, supporting their potential use for prioritizing robust pathway-level drug-response correlates.
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- gtexture: novel extension of image texture analysis to graphs and its application to cancer informatics
Rowan J Barker-Clarke, Davis T. Weaver, Jacob G. Scott·bioRxiv·Nov 21, 2022
- Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach
M. Pouryahya, J. H. Oh, … A. R. Tannenbaum·bioRxiv·Nov 22, 2017
- Robust and clinically relevant prediction of response to anti-cancer drugs via network integration of molecular profiles
M. Franco, A. Jeggari, … A. Alexeyenko·bioRxiv·Aug 21, 2018
- OmicsNet: Integration of Multi-Omics Data using Path Analysis in Multilayer Networks
Murodzhon Akhmedov, Alberto J. Arribas, … Ivo Kwee·bioRxiv·Dec 22, 2017
- Sparse network-based regularization for the analysis of patientomics high-dimensional survival data
André Veríssimo, Eunice Carrasquinha, … Susana Vinga·bioRxiv·Aug 30, 2018
- ORN: Extracting Latent Pathway Activities in Cancer with OR-gate Network
Lifan Liang, Kunju Zhu, Songjian Lu·bioRxiv·Jun 7, 2020